InterCure to Hold 2021 Q4 & Year-End Webcast
31 March 2022 - 12:00AM
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba
Canndoc) ("InterCure" or the “Company”) today announced that it
plans to release financial results for the fourth quarter of 2021
after market close on Thursday, March 31, 2022. The Company will
conduct a webcast on Monday, April 4, 2022 at 8:30 a.m. (Eastern
Time) to review the results as well as provide an overview of the
Company’s recent milestones and growth strategy.
To access the conference call, United States
participants please dial (844) 310-5056, or for international
callers, 1-706-679-4749. Conference ID: 5661207.
Participants can access the live webcast through
the following link:https://bit.ly/37N92wN
A live webcast of the conference call can be
accessed on the ‘Events and Presentations’ section of the InterCure
website at http://www.intercure.co.
About InterCure (dba
Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX:
INCR.U) (TASE: INCR) is the leading, profitable, and fastest
growing cannabis company outside of North America. Canndoc, a
wholly owned subsidiary of InterCure, is Israel’s largest licensed
cannabis producer and one of the first to offer Good Manufacturing
Practices (GMP) certified and pharmaceutical-grade medical cannabis
products. InterCure leverages its market leading distribution
network, best in class international partnerships and a high-margin
vertically integrated "seed-to-sale" model to lead the fastest
growing cannabis global market outside of North America.
For more information, visit:
http://www.intercure.co.
Contact:
InterCure Ltd.Amos Cohen, Chief Financial
Officeramos@intercure.co
Intercure (TSX:INCR.U)
Historical Stock Chart
From Sep 2024 to Oct 2024
Intercure (TSX:INCR.U)
Historical Stock Chart
From Oct 2023 to Oct 2024